Cepheid
Cepheid
Cepheid
Overview
Date Founded
Headquarters
Type of Company
Employees (Worldwide)
Industries
Company Description
Website
Contact Data
In The News
Nasdaq
January 14, 2021
GlobeNewswire
January 13, 2021
PR Newswire
December 23, 2020
Business Wire
December 18, 2020
Executives & Employees
President & Chief Operating Officer
Senior Vice President & General Manager
Chief Medical & Technology Officer
Executive Vice President, Worldwide Commercial Operations
Co-Founder
Co-Founder
Executive Director
Executive Director
Executive Director
Partner
Board of Directors
Special Limited Partner at CampVentures LLC
Former Vice Chairman at New York Biotechnology Association, Inc.
Chief Medical & Technology Officer at Cepheid
Former Director at ACLARA Biosciences, Inc.


Recent Transactions



Transaction Advisors
Legal Advisor
Underwriter
Underwriter
Associate
Legal Advisor
Co-Chair, Mergers & Acquisitions
Advisors & Consultants
Key Stats and Financials As of
Market Capitalization
Total Enterprise Value
Earnings Per Share
Non-Profit Donations & Grants
$10K - $25K
2018
$10K - $25K
2017
$10K - $25K
2017
Non-Profit Donations & Grants Received
$1.37M
12/31/2016
$1.01M
12/31/2015
$2.37M
12/31/2014
Investors



Suppliers
bioMérieux SA
Industrial Machinery & Manufacturing | Marcy l’etoile, France
Thermo Fisher Scientific, Inc.
Computer Software | Waltham, Massachusetts
Oregon Health & Science University
Hospitals & Patient Services | Portland, OR
Competitors
Abbott Laboratories
Pharmaceuticals - Abbott Park, Illinois
Thermo Fisher Scientific, Inc.
Industrial Machinery & Manufacturing - Waltham, Massachusetts
Roche Holding AG
Pharmaceuticals - Basel, Switzerland
This web site is not endorsed by, directly affiliated with, maintained, authorized, or
sponsored by Cepheid. The use of any trade name or trademark is for identification and
reference purposes only and does not imply any association with the trademark holder. The
Presence of Cepheid's profile does not indicate a business or promotional relationship of
any kind between RelSci and Cepheid.